| Metric | H1 FY27 | H1 FY26 | |
|---|---|---|---|
| Revenue from operations | 43.7 | — | 25.3 |
| Other income | 0.3 | — | 0.3 |
| Total income | 44.0 | — | 25.6 |
| Profit before exceptional items & tax | 4.8 | — | -1.0 |
| Profit before tax | 4.8 | — | -1.0 |
| Net profit | 3.5 | — | -0.8 |
| Operating margin | 10.9% | — | -3.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +72.70% |
|---|---|
| Operating profit, year on year | +446.20% |
NSE results filing, NSE: AAKAAR. Figures extracted from the filing.
Aakaar Medical Technologies Ltd: key numbers
- Share price
- ₹71.00
- Market cap
- ₹100.6 Cr
- Revenue (annual)
- ₹66.96 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 15.2×Sector 52.3×
- Promoter holding
- 67.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aakaar Medical Technologies Ltd
All →Aakaar Medical Technologies Investor Presentation: Key Takeaways
H1 FY27 revenue ₹43.72 Cr (+72.6% YoY), EBITDA ₹5.43 Cr (12.42%), PAT ₹3.54 Cr vs prior loss ₹0.78 Cr. Strategy: doctor-led B2B2C distribution, Xelix clinic network, debtor-days reduction.
Aakaar Medical Technologies Board Meeting Date
Aakaar Medical Technologies Limited will hold a board meeting on 30-Oct-2026 to consider unaudited half-yearly financial results and ESOP matters.
Aakaar Medical Technologies Other Announcement
Aakaar Medical Technologies Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026. The report confirms total issued capital remains at 1,41,72,816 equity shares.
Aakaar Medical Technologies Business Update
Aakaar Medical Technologies provided an operational update for Q1 FY2026-27, detailing expansion in its clinic network, distributor count, and overall sales force effectiveness.
Aakaar Medical Technologies Legal & Regulatory
Aakaar Medical Technologies addressed an NSE notice regarding Regulation 44(3) non-compliance, stating the lapse was inadvertent and that corrective measures have been implemented.
Aakaar Medical Technologies Legal & Regulatory
Aakaar Medical Technologies submitted a share‑capital audit reconciliation reporting issued capital of ₹14.17 Crore. The filing satisfies SEBI (Depositories and Participants) Regulation 76 requirements.
- Value
- ₹14.17 Cr